Viewing Study NCT06095492


Ignite Creation Date: 2025-12-24 @ 3:39 PM
Ignite Modification Date: 2026-02-03 @ 1:41 AM
Study NCT ID: NCT06095492
Status: RECRUITING
Last Update Posted: 2024-12-05
First Post: 2023-09-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Empagliflozin vs Linagliptin on Glycemic Outcomes,Renal Outcomes & Body Composition in Renal Transplant Recipients With Diabetes Mellitus
Sponsor: Medanta, The Medicity, India
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Kidney Transplant; Complications View
None Diabetes Mellitus View
Keywords: